Open AccessDevelopment and Validation of a Prognostic Nomogram for Progression-Free Survival in Patients with Advanced Renal Cell Carcinoma Treated with Pazopanib
Author(s) -
Michael W. Kattan,
Cora N. Sternberg,
Faisal Mehmud,
Kamal Bhatt,
Lauren McCann,
Robert J. Motzer
Publication year - 2015
Publication title -
oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.987
H-Index - 98
eISSN - 1423-0232
pISSN - 0030-2414
DOI - 10.1159/000430989
Subject(s) - pazopanib , nomogram , medicine , oncology , renal cell carcinoma , proportional hazards model , progression free survival , urology , kidney cancer , overall survival , sunitinib
To develop and validate a prognostic nomogram for predicting the probability of 12-month progression-free survival (PFS) for patients receiving first-line pazopanib for advanced renal cell carcinoma (RCC).
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom